Verastem to Present at Cantor Fitzgerald’s Inaugural Health Care Conference

BOSTON, Mass.--(BUSINESS WIRE)-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the Cantor Fitzgerald Inaugural Health Care Conference on Wednesday, July 8 at 2:00 p.m. ET at Le Parker Meridien Hotel in New York City.

A live webcast of the presentation will be available on the company's website at http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-calendar. An archived presentation will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ: VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150702005151/en/

Verastem, Inc.
Brian Sullivan, 781-292-4214
[email protected]

Source: Verastem, Inc.

You May Also Be Interested In

• Verastem data on ovarian cancer drug combo set for IGCS 2026
• XCF Global (NASDAQ:SAFX) Announces August Revenue of More Than $10 Million From Shipment of 1.3M Gallons of Renewable Fuel
• Last Chance to See Hunt Slonem's Through the Looking Glass at One Art Space